| Ident. | Authors (with country if any) | Title |
|---|
| 000125 (2013) |
K. A. Papp [Canada] ; R. G. Langley [Canada] ; B. Sigurgeirsson [Islande] ; M. Abe [Japon] ; D. R. Baker [États-Unis] ; P. Konno [Estonie] ; S. Haemmerle [Suisse] ; H. J. Thurston [Suisse] ; C. Papavassilis [Suisse] ; H. B. Richards [Suisse] | Efficacy and safety of secukinumab in the treatment of moderate‐to‐severe plaque psoriasis: a randomized, double‐blind, placebo‐controlled phase II dose‐ranging study |
| 000126 (2013) |
Marjolein A. Van Der Marck [Pays-Bas] ; Bastiaan R. Bloem [Pays-Bas] ; George F. Borm [Pays-Bas] ; Sebastiaan Overeem [Pays-Bas] ; Marten Munneke [Pays-Bas] ; Mark Guttman [Canada] | Effectiveness of multidisciplinary care for Parkinson's disease: A randomized, controlled trial |
| 000148 (2013) |
| A randomized, double‐blind, placebo‐controlled trial of pridopidine in Huntington's disease |
| 000149 (2013) |
D. William Molloy [Irlande (pays)] ; T. I. Standish [Canada] ; Q. Zhou [Canada] ; G. Guyatt [Canada] | A multicenter, blinded, randomized, factorial controlled trial of doxycycline and rifampin for treatment of Alzheimer's disease: the DARAD trial |
| 000244 (2012) |
James L. Gonzaga ; John B. Grande ; John B. Brook | Morphology‐Controlled Synthesis of Poly(oxyethylene)silicone or Alkylsilicone Surfactants with Explicit, Atomically Defined, Branched, Hydrophobic Tails |
| 000321 (2012) |
Olivier Rascol [France] ; Joaquim Ferreira [Portugal] ; Laurence Nègre-Pages [France] ; Santiago Perez-Lloret [France] ; Lucette Lacomblez [France] ; Monique Galitzky [France] ; Jean-Christophe Lemarié [France] ; Jean-Christophe Corvol [France] ; Jonathan M. Brotchie [Canada] ; Laura Bossi [France] | A proof‐of‐concept, randomized, placebo‐controlled, multiple cross‐overs (n‐of‐1) study of naftazone in Parkinson’s disease |
| 000323 (2012) |
Roger Kurlan [États-Unis] ; Giovanna Crespi [États-Unis] ; Barbara Coffey [États-Unis] ; Kirsten Mueller-Vahl [Allemagne] ; Stephen Koval [États-Unis] ; Glen Wunderlich [Canada] | A multicenter randomized placebo‐controlled clinical trial of pramipexole for Tourette's syndrome |
| 000326 (2012) |
Jo Watson [Canada] ; Ellen Hodnett ; B. Anthony Armson ; Barbara Davies ; Judy Watt-Watson | A Randomized Controlled Trial of the Effect of Intrapartum Intravenous Fluid Management on Breastfed Newborn Weight Loss |
| 000478 (2011) |
Daniela Berg [Allemagne] ; Jana Godau [Allemagne] ; Claudia Trenkwalder [Allemagne] ; Karla Eggert [Allemagne] ; Iiona Csoti [Allemagne] ; Alexander Storch [Allemagne] ; Heiko Huber [Allemagne] ; Monica Morelli-Canelo [Allemagne] ; Maria Stamelou [Allemagne] ; Vincent Ries [Allemagne] ; Martin Wolz [Allemagne] ; Christine Schneider [Allemagne] ; Thérèse Di Paolo [Canada] ; Fabrizio Gasparini [Suisse] ; Sam Hariry [Suisse] ; Marc Vandemeulebroecke [Suisse] ; Walid Abi-Saab [Suisse] ; Katy Cooke [Royaume-Uni] ; Donald Johns [Suisse] ; Baltazar Gomez-Mancilla [Suisse] | AFQ056 treatment of levodopa‐induced dyskinesias: Results of 2 randomized controlled trials |
| 000791 (2009) |
Behzad Elahi [Canada] ; Behrad Elahi [Iran] ; Robert Chen [Canada] | Effect of transcranial magnetic stimulation on Parkinson motor function—Systematic review of controlled clinical trials |
| 000824 (2009) |
Peter J. Trainer [Royaume-Uni] ; Shereen Ezzat [Canada] ; Gwyn A. D Ouza [Royaume-Uni] ; Gary Layton [Royaume-Uni] ; Christian J. Strasburger [Allemagne] | A randomized, controlled, multicentre trial comparing pegvisomant alone with combination therapy of pegvisomant and long‐acting octreotide in patients with acromegaly |
| 000966 (2008) |
C. Warren Olanow [États-Unis] ; Robert A. Hauser [États-Unis] ; Joseph Jankovic [États-Unis] ; William Langston [États-Unis] ; Anthony Lang [Canada] ; Werner Poewe [Autriche] ; Eduardo Tolosa [Espagne] ; Fabrizio Stocchi [Italie] ; Eldad Melamed [Israël] ; Eli Eyal [Israël] ; Olivier Rascol [France] | A randomized, double‐blind, placebo‐controlled, delayed start study to assess rasagiline as a disease modifying therapy in Parkinson's disease (the ADAGIO study): Rationale, design, and baseline characteristics |
| 000A40 (2007) |
Dan A. Mendonça [Canada] ; Krishe Menezes [Canada] ; Mandar S. Jog [Canada] | Methylphenidate improves fatigue scores in Parkinson disease: A randomized controlled trial |
| 000B43 (2006) |
Jane A. Gilbertson ; Arindom Sen ; Leo A. Behie ; Michael S. Kallos | Scaled‐up production of mammalian neural precursor cell aggregates in computer‐controlled suspension bioreactors |
| 000B46 (2006) |
Anthony E. Lang [Canada] ; Steven Gill [Royaume-Uni] ; Nik K. Patel [Royaume-Uni] ; Andres Lozano [Canada] ; John G. Nutt [États-Unis] ; Richard Penn [États-Unis] ; David J. Brooks [Royaume-Uni] ; Gary Hotton [Royaume-Uni] ; Elena Moro [Canada] ; Peter Heywood [Canada] ; Matthew A. Brodsky [États-Unis] ; Kim Burchiel [États-Unis] ; Patrick Kelly [États-Unis] ; Arif Dalvi [États-Unis] ; Burton Scott [États-Unis] ; Mark Stacy [États-Unis] ; Dennis Turner [États-Unis] ; V. G. Frederich Wooten [États-Unis] ; William J. Elias [États-Unis] ; Edward R. Laws [États-Unis] ; Vijay Dhawan [États-Unis] ; A. Jon Stoessl [Canada] ; James Matcham [Royaume-Uni] ; Robert J. Coffey [États-Unis] ; Michael Traub [États-Unis] | Randomized controlled trial of intraputamenal glial cell line–derived neurotrophic factor infusion in Parkinson disease |
| 000E92 (2003) |
C. Warren Olanow [États-Unis] ; Christopher G. Goetz [États-Unis] ; Jeffrey H. Kordower [États-Unis] ; A. Jon Stoessl [Canada] ; Vesna Sossi [Canada] ; Mitchell F. Brin [États-Unis] ; Kathleen M. Shannon [États-Unis] ; G. Michael Nauert [États-Unis] ; Daniel P. Perl [États-Unis] ; James Godbold [États-Unis] ; Thomas B. Freeman [États-Unis] | A double‐blind controlled trial of bilateral fetal nigral transplantation in Parkinson's disease |
| 000F48 (2002) |
G. B Lumer [Canada] ; D. Roy [Canada] ; M. Talajic [Canada] ; A. Couturier [Canada] ; J. Lambert [Canada] ; N. Frasure-Smith [Canada] ; B. Thibault [Canada] ; M. Dubuc [Canada] ; P. Gagne [Canada] ; S. Nattel [Canada] | Amiodarone reduces procedures and costs related to atrial fibrillation in a controlled clinical trial |
| 000F51 (2002) |
Rubia P. Meshack ; Kathleen E. Norman [Canada] | A randomized controlled trial of the effects of weights on amplitude and frequency of postural hand tremor in people with Parkinson's disease |
| 000F86 (2001) |
J. Thomas Hutton [États-Unis] ; Leo Verhagen Metman [États-Unis] ; Thomas N. Chase [États-Unis] ; Jorge L. Juncos [États-Unis] ; William C. Koller [États-Unis] ; Rajesh Pahwa [États-Unis] ; Peter A. Lewitt [États-Unis] ; Ali Samii [Canada] ; Joseph K. C. Tsui [Canada] ; Donald B. Calne [Canada] ; Cheryl H. Waters [États-Unis] ; Vincent P. Calabrese [États-Unis] ; James P. Bennett [États-Unis] ; Richard Barrett [États-Unis] ; Jerry L. Morris [États-Unis] | Transdermal dopaminergic D2 receptor agonist therapy in Parkinson's disease with N‐0923 TDS: A double‐blind, placebo‐controlled study |
| 001099 (2001) |
Andrew D. Krahn [Canada] ; George J. Klein [Canada] ; Raymond Yee [Canada] | A Randomized, Double‐Blind, Placebo‐Controlled Evaluation of the Efficacy and Safety of Intravenously Administered Dofetilide in Patients with Wolff‐Parkinson‐White Syndrome |
| 001264 (2000) |
Jane Schneiderman-Walker [Irlande (pays)] ; Susan L. Pollock [Irlande (pays)] ; Mary Corey [Irlande (pays)] ; Donna D. Wilkes [Irlande (pays)] ; Gerard J. Canny [Irlande (pays)] ; Linda Pedder [Irlande (pays)] ; J. Joseph Reisman [Irlande (pays)] | A randomized controlled trial of a 3-year home exercise program in cystic fibrosis |
